- 2016: Eumedica’s 30 year anniversary
- 2015: Launch of Negaban® in France
- 2014: Increase in our storage capacities (up to 10,000 m²)
- 2014: Acquisition of Farmastur (Eumedica Pharmaceuticals Industries), a chemical and pharmaceutical production unit located in Llanara, Spain, a manufacturer of injectable penicillin for the global market
- 2013: Distribution of our antipsychotics product range (Dipiperon®, Orap®, Imap®, Impromen Decanoas® and Impromen®)
- 2012: Extension of our logistics centre
- 2009: Distribution of Somatostatine® worldwide
- 2007: Another of the top ten pharmaceutical multinationals trusts Eumedica for the distribution of their clinical trial products
- 2006: Launch of Negaban® in the United Kingdom
- 2006: Launch of Somatostatine-Eumedica® in Belgium
- 2004: Launch of Actosolv® in France
- 2003: Eumedica moves to its new distribution centre in Manage
- 2002: Expansion of Eumedica’s product portfolio with the acquisition of: Dopram®, Robinul®, and Robinul Neostigmine®, Actosolv®, Pre-Par®
- 2002: One of the largest pharmaceutical multinationals chooses Eumedica to distribute their clinical trial products throughout Europe
- 1998: Distribution of the Negaban® (Temocillin)
- 1986: Creation of Belpharma specialised in Regulatory Affairs and monitoring of clinical trials
This website uses cookies to improve your experience. You may block the use of cookies, however, some are essential for the website to operate properly. Please select “Accept” below to confirm that you have read and accept the terms of our cookie policy.Accept Read More Privacy & Cookies Policy
